CDKN1B and neoplasm: b-AP15 is a small inhibitor of deubiquitinating enzymes USP14/UCHL5, and treatment with b-AP15 induces tumor regression and upregulates p27 protein level in tumors with p53 deficiency (Jiang et al., 2022).